Editorial introductions
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Abstract
Current Opinion in Pulmonary Medicine was launched in 1995. It is one of a successful series of review journals whose unique format is designed to provide a systematic and critical assessment of the literature as presented in the many primary journals. The field of pulmonary medicine is divided into nine sections that are reviewed once a year. Each section is assigned a Section Editor, a leading authority in the area, who identifies the most important topics at that time. Here we are pleased to introduce the Journal's Section Editors for this issue. SECTION EDITORS Alimuddin ZumlaAlimuddin ZumlaProfessor Sir Alimuddin Zumla Kt., GCDS., MD., PhD., FRCP., FRCPath., FRSB., FAAS., MAE., is Professor of Infectious Diseases and International Health in the Division of Infection and Immunity, University College London, and is Consultant Infectious Diseases Physician at University College London Hospitals NHS Foundation Trust, United Kingdom. He serves as honorary and visiting Professor at several institutions in the UK, Africa, Europe, and the Middle East. Sir Zumla is an internationally renowned clinician-scientist who is dually qualified in Medicine (MBChB) and Science (PhD). He has an excellent global reputation for being a deeply committed and caring physician who has made major health-policy changing contributions to new medical and knowledge through innovative and impactful national and global priority research, effectively bridging the gap between “bench” (laboratory science) and “bedside” (hospital and community patient care). He is accredited as a specialist in Infectious Diseases, Internal Medicine and Clinical immunology. Sir Ali is a Fellow of the: 1). World Academy of Sciences, 2). Royal Colleges of Physicians of London. 3). Royal College of Physicians of Edinburgh; 4). Royal College of Pathologists; 5). Royal Society of Biology and 6). African Academy of Sciences. He was elected to the Membership of the prestigious Academia Europaea in January 2024. As a BEIT Scholar he obtained an MSc in Tropical Medicine (with Distinction & the Murgatroyd prize-1982). He obtained his PhD (awarded the Alan Woodruff Medal-1987) from The London School of Hygiene & Tropical Medicine. Sir Ali received international acclaim for rapidly identifying & notifying the 1988 Legionnaires’ disease outbreak which he traced back to BBC Broadcasting House, central London whilst working as an infectious diseases’ registrar at Rush Green Hospital, Romford - brilliance that was highlighted in Parlimentary and West Minster City reports and re-enacted in the BBC London Program. After 4 years as Senior Registrar at the Hammersmith Hospital(RPMS) London, he spent 2 years as Associate Professor at the School of Public Health, University of Texas Health Science Centre, Houston, USA, & Visiting Professor at UNZA-School of Medicine, UTH in Lusaka, before appointment as Professor of Infectious Diseases and International Health at University College London, and Consultant Infectious Diseases Physician at UCLHospitals, in 1994. Since then, Sir Ali skilfully pioneered and championed a new discipline of ‘Global Health’ at UCL with significant global impact, effectively networking numerous institutions across all continents, achieving ‘unity of purpose’ for tackling poverty-related diseases and infectious diseases with epidemic potential through a novel ONE-HUMAN-ANIMAL-HEALTH (ONE-HEALTH) approach. In 1989, Sir Zumla pioneered the concepts of: a) ’Equitable and Fair North-South R&D partnerships, dismantling colonial models of research operating in Africa, and b). Close alignment of capacity development and training with high quality, health policy relevant research. His teams won the prestigious Times Higher Education ’Best international Collaboration’ Award (2013) and the EU-EDCTP ‘Most outstanding ‘Africa-Europe’ Team Award’(Nov.2016). Sir Ali has been awarded over 35 prestigious national and international awards/prizes and medals. Recent awards include: Mahathir Science Award (2020)-the most prestigious global award for Tropical Sciences; EU-EDCTP Pascoal Mocumbi Award (2021); The RSTMH Sir Manson Medal(2022) -the highest honour of the Royal Society of Tropical Medicine and Hygiene (this was the first time in a hundred years that the RSTM&H awarded this medal to a non causcasian academic). In November 2024 Sir Zumla was awarded the UCL Hospitals NHS Foundation Trust Long Service Lifetime Achievement Award. Sir Ali has over 1,000 publications and featured annually in the Clarivate Lists (2018–2025) of the world's most influential and highly cited researchers. He is Editor of 22 medical textbooks, including globally acknowledged classics: Manson's Tropical Diseases (co-edited with Gordon Cook), Tuberculosis: A Comprehensive Clinical Reference (co-edited with Simon Schaaf), Granulomatous Disorders (co-edited with Geraint James) and Tuberculosis-Perspectives in Medicine (co-edited with Stefan Kaufmann and Eric Ruben). He is senior co-editor of the Handbook of Refugee Health for Healthcare Professionals and Humanitarians Providing Care to Forced Migrants. Sir Ali has led several specialist journal theme series and ‘state of the art’ update reviews on TB, RTIs, Mass Gatherings Medicine, ONE-HEALTH, and AMR involving a global authorship, for continuing medical education and for dissemination the latest literature to health personnel and scientists in low- and middle-income countries. David Shu-Cheong HuiDavid Shu-Cheong HuiProf. David Hui, MBBS; MD; FRACP; FRCP; FHKCP; FHKAM is the Director, SH Ho Research Centre for Infectious Diseases and Chairman plus Stanley Ho Professor of Respiratory Medicine, Department of Medicine & Therapeutics at The Chinese University of Hong Kong. Prof. Hui graduated from the University of New South Wales, Australia, in 1985 and then trained in Respiratory Medicine and Sleep Medicine in Sydney, Australia. He was heavily involved in the clinical management of patients with SARS at the Prince of Wales Hospital during the major outbreak in 2003. He served as a WHO advisor to review the clinical management of influenza A(H5N1) during the early human outbreak in Vietnam in Feb 2004 and has since been a regular advisor to the WHO on the clinical management of severe acute respiratory infections. He joined urgent WHO missions for investigation of outbreaks of MERS in Riyadh and South Korea in 2013 and 2015 respectively. He has contributed to the WHO treatment guidelines including the clinical management of influenza A (H5N1) virus in 2007, clinical management of influenza A (H1N1) pandemic in 2009, and the Middle East Respiratory Syndrome (MERS) and the WHO training workshop in the clinical management of influenza A(H7N9) and COVID-19. He served as an advisor to the HKSAR government on COVID-19 from Jan 2020 to May 2023 and has been the Chairman of the Scientific Committee on Emerging and Zoonotic Diseases under the Center for Health Protection, HKSAR Government, since 2019. Dr Hui has published over 450 peer-reviewed journal articles and 24 book chapters since joining the CUHK in 1998. He was the top 1% highly cited researcher (cross fields) in 2021, 2022 and 2023 assessed by Clarivate, and the World's top 2% scientists since 2021 in addition to being ranked within top 10 in respiratory medicine from 2021 to 2023 (Stanford University, Mendeley Data). His research interests include clinical management of emerging severe acute respiratory infections, the safety of respiratory therapy in the post SARS era, the efficacy of the medical ward airflow in preventing nosocomial infections, sleep disordered breathing, and common airway diseases. Sandhya KhuranaSandhya KhuranaDr Sandhya Khurana is an adult pulmonary and critical care physician with a specialized focus in management of severe and difficult asthma. She is currently a Professor of Medicine at the University of Rochester School of Medicine and Dentistry in Rochester, NY, USA. Dr Khurana's clinical and research interests include comprehensive multidisciplinary management of severe asthma. She believes in a patient-centered and team-based approach to management of this complex condition. She has expertise in application of novel therapies for severe asthma including new monoclonal antibodies. She is the site principal investigator in several multicenter clinical trials evaluating new treatments in asthma. Dr Khurana has chaired asthma-focused sessions and participated as faculty at national and international meetings. She has co-authored peer-reviewed papers and guidelines on asthma. She is the co-editor of the textbook “Difficult to Treat Asthma: Clinical Essentials”. She is an Associate Editor for the European Respiratory Review journal of the ERS. She has served on the American Thoracic Society/European Respiratory Society's joint taskforce on severe asthma and on utility of fractional exhaled nitric oxide in asthma. Dr Khurana has several leadership roles in the American College of Chest Physicians (CHEST) and serves on the Board. She is the past Chair of Airway Disorders NetWork of the American College of Chest Physicians. Christian TaubeChristian TaubeChristian Taube is a Professor of Pulmonary Medicine and Chairman of the Department of Pulmonary Medicine, University Hospital Essen – Ruhrlandklinik, Germany. His research interest includes airway immunology and airway inflammation in airway disease. He has been active in translational and clinical research for asthma and COPD. He is involved in different basic, translational and multicenter clinical projects. Christian Taube is involved in the European Respiratory Society (ERS) and is currently the incoming president for the German Respiratory Society.
Publication details
- Journal / source
- Current Opinion in Pulmonary Medicine
- Volume
- 32
- Issue
- 3
- Pages
- v–vii
- Publication date
- 26 March 2026
- Language
- EN